脑机接口重大突破来了！这家公司登顶Nature子刊后，刚融资3亿

Core Viewpoint - The article discusses the recent A+ round financing of Zhiran Medical, a company specializing in invasive flexible electrode brain-machine interfaces, which raised 300 million RMB to advance clinical trials and product iterations [4][6]. Financing Overview - Zhiran Medical completed its A+ round financing on February 11, 2026, raising 300 million RMB, led by Zhongke Chuangxing, with participation from various investors including Legend Capital and IDG Capital [4][5]. - The company has a history of financing rounds, including over 300 million RMB in its A round in July 2025 and undisclosed amounts in earlier rounds [5]. Technological Advancements - The company has developed a new type of stretchable flexible electrode that addresses the core issues of traditional electrodes, such as displacement and detachment in the brain, allowing for precise and stable neural signal collection [4][15]. - This innovative technology significantly reduces mechanical damage to brain tissue, with the required stretching force being only 1/100 of that needed for traditional linear electrodes [15][12]. Product and Market Strategy - Zhiran Medical's core product is an invasive flexible brain-machine interface platform, which includes flexible electrodes, hardware systems, software, and decoding algorithms [11]. - The company aims to meet clinical needs by developing products that assist patients with paralysis, blindness, and neurological disorders [6][9]. Clinical Applications and Collaborations - The company has initiated collaborations with hospitals for clinical implantation surgeries, including a successful ultra-thin flexible deep electrode implantation in November 2024 [24]. - Zhiran Medical's digital EEG machine, capable of 1024-channel signal collection, received market approval in May 2025, catering to diverse clinical and research needs [20][21]. Production Capabilities - The company has established its own production facility for clinical-grade flexible electrodes, with a cleanroom area of nearly 2000 square meters, achieving mass production capabilities [24]. - The electrode implantation robot developed by Zhiran Medical enhances precision and efficiency in surgical procedures, reducing the time for single electrode implantation to under 30 seconds [18][19]. Future Outlook - Zhiran Medical plans to accelerate the clinical rollout of its products, with large-scale registration of over 100-channel invasive brain-machine interface products expected to start in 2026 [26]. - The long-term vision of the company is to bridge the gap between humans and machines, ultimately enhancing human brain functions [26].